Thin
Direct supply from our multi-ton chemical synthesis platform. Qualified analytical documentation including RP-HPLC, LC-MS identity, and residual solvent quantification provided with every batch.
A rigorous review of sequence fidelity, blood-brain barrier transport, and physiological regulation of slow-wave sleep rhythms.
Delta Sleep-Inducing Peptide is a well-characterized nonapeptide with the native sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (H-WAGGDASGE-OH, CAS No. 62568-57-4). Our solid-phase platform guarantees minimal truncated diastereomers and racemization control at the sensitive Asp-Ala hinge.
Unlike classical gamma-aminobutyric acid (GABA-A) modulators and hypnotic barbiturates, DSIP functions as an endogenous neuromodulator. It induces delta (slow-wave) spindle rhythms without suppressing REM phases, normalizing endogenous circadian machinery without motor ataxia.
Extensive clinical and animal paradigms demonstrate that DSIP downregulates systemic corticotropin-releasing hormone (CRH) release, modulates adrenocorticotropic hormone (ACTH) surges under acute oxidative stress, and protects cellular mitochondria from free-radical cascades.
Analyzing geopolitical demand surges, supply-chain constraints, and the transformation toward scalable synthetic biology.
The global incidence of chronic sleep fragmentation, circadian dysregulation in shift-workers, and treatment-resistant insomnia has accelerated investment in non-addictive, targeted peptide therapeutics, multiplying institutional demand for bulk DSIP.
Global agencies like the US FDA and EMA require stringent limits on peptide-related impurities and diastereomers. Hangzhou Thinheal implements QbD (Quality by Design) to assure DMF-ready analytical data packages for commercial buyers.
As small-batch suppliers face solvent-handling challenges and environmental quotas, capacity concentrates among large-scale facilities like Thinheal's Hangzhou site, guaranteeing reliable supply agreements across the Americas, Europe, and Asia.
DSIP requires strict stability monitoring. Modern peptide logistics integrate temperature-controlled vacuum lyophilization, argon gas inerting, and real-time data loggers ensuring viability at standard -20°C storage destinations.
A detailed view of solid-phase peptide synthesis (SPPS), cleavage parameters, preparative chromatography, and process quality control.
Coupling the labile Trp1 to Glu9 sequence on 2-chlorotrityl chloride (CTC) resin prevents C-terminal epimerization. We deploy DIC/Oxyma pure coupling chemistry with controlled thermal profiles to avoid Asp5 aspartimide formation.
Crude DSIP undergoes dynamic axial compression (DAC) column chromatography using C18 stationary phases. Gradient elution using TEAP/Acetonitrile followed by volatile ammonium acetate facilitates counter-ion exchange to pure acetate or hydrochloride salts.
Primary shelf sublimation (-45°C to -10°C) over 48 hours followed by secondary isothermal desorption drives residual moisture under 3.0%. The final product is an amorphous, white, sterile cake that dissolves instantly in standard saline.
| Analytical Parameter | Methodology / Instrumentation | Thinheal Commercial Specification | Typical Batch Lot Results |
|---|---|---|---|
| Chemical Identification | LC-ESI-MS / High-Res Orbitrap | 848.81 ± 1.0 Da | 848.79 Da (Conforms) |
| Chromatographic Purity | Reversed-Phase HPLC (RP-HPLC at 220 nm) | ≥ 98.0% (Pharma/Research Grade) | 99.42% (Ultra-Trace Single Impurity) |
| Net Peptide Content | Elemental Nitrogen Analysis (Kjeldahl) | ≥ 80.0% | 85.6% (Balance: Counter-ion & H2O) |
| Bacterial Endotoxins | Limulus Amebocyte Lysate (LAL Kinetic) | ≤ 5.0 EU/mg (Injectable grade available) | < 0.02 EU/mg |
| Residual Solvents | Headspace Gas Chromatography (GC-MS) | Acetonitrile < 410 ppm, DMF < 880 ppm | Conforms to USP <467> Step 1 |
From neuropsychiatric protocols to metabolic longevity matrices, explore active DSIP applications across global markets.
Investigated extensively in central and eastern research centers for its ability to stabilize cerebral neuronal activity during acute ischemia. DSIP dampens excitotoxic glutamate pathways and prevents lipid peroxidation in basal ganglia models.
Clinical observation protocols in European psychiatric initiatives demonstrate DSIP's role in dampening adrenergic autonomic hyperactivity during opiate and alcohol detoxification, helping stabilize sleep-wake architecture in recovering cohorts.
Beyond simple sleep induction, deep delta sleep drives glymphatic clearance of metabolic waste, including beta-amyloid. Ongoing studies evaluate DSIP's longevity potential via nightly maintenance of growth hormone pulsatility.
Transparent B2B reference pricing for global research institutions, formulation labs, and commercial generic pharmaceutical distributors.
| Tier / Order Volume | Purity Threshold | Packaging Format | Unit Price (USD Estimate) | Fulfillment Lead Time |
|---|---|---|---|---|
| Pilot / Validation (10g – 50g) | ≥ 98.0% (HPLC) | Sterile Borosilicate Vials (10mg/50mg) | Request Custom Quote | Immediate Dispatch (In Stock) |
| Mid-Scale Pre-Clinical (100g – 500g) | ≥ 98.5% (HPLC) | Fluoropolymer Coated HDPE Containers | Tier 2 Volume Discount | 3 – 5 Business Days |
| Bulk Formulation (1kg – 5kg) | ≥ 99.0% (Pharma Grade) | Pharmaceutical Grade Vacuum Aluminum Drum | Direct API Wholesale Pricing | Scheduled Commercial Dispatch |
| Multi-Kilogram Contract CDMO | Custom Defined Specs | Custom Cleanroom Purged Packaging | Annual Blanket Master Agreement | Dedicated Synthesis Campaign |
*Note: Final quote values depend on salt exchange (Acetate vs. Trifluoroacetate vs. HCl), sterility certification levels, and custom batch documentation requirements. Contact your regional export desk for a signed quotation.
Answers to technical specifications, stability profiles, qualification documentation, and international shipping protocols.
Explore our broader peptide pipeline, backed by dedicated process chemistry teams and commercial multi-ton capacity.
